Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like Fatal nitrofurantoin lung. October 3, 2013 Pneumocystis pneumonia. September 20, 2004 Why “STOP TB” is incomplete without “QUIT SMOKING”. January 14, 2011 Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019 Macitentan and morbidity and mortality in pulmonary arterial hypertension. August 29, 2013
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019